This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Cardinal Health (CAH) Gets a Buy from William O’Neil

Tipranks - Tipranks - Tue Jun 16, 6:52AM CDT

Cardinal Health received a Buy rating and price target from William O’Neil analyst on June 12. The company’s shares closed last Friday at $223.85.

Claim 55% Off TipRanks

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cardinal Health with a $246.00 average price target, implying a 9.90% upside from current levels. In a report released on June 10, Barclays also maintained a Buy rating on the stock with a $258.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on Cardinal Health’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $60.94 billion and a net profit of $399 million. In comparison, last year the company earned a revenue of $54.88 billion and had a net profit of $506 million

Read More on CAH:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).